ABCA5 | ATP-binding cassette, sub-family A (ABC1), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ADCY10 | Adenylate cyclase 10 (soluble) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
APH1B | APH1B gamma secretase subunit | Predicted membrane proteins
| | | | | Expressed in all |
AQP1 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000421315} | Predicted membrane proteins
| | | | | Not detected |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP7 | Aquaporin 7 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
ARL6IP1 | ADP-ribosylation factor-like 6 interacting protein 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARV1 | ARV1 homolog (S. cerevisiae) | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP10D | ATPase, class V, type 10D | Enzymes Predicted membrane proteins
| | | | | Mixed |
ATP11B | ATPase, class VI, type 11B | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A4 | ATPase type 13A4 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
ATP6V0B | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b | Predicted membrane proteins
| | | | | Expressed in all |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
C5orf28 | Chromosome 5 open reading frame 28 | Predicted membrane proteins
| | | | | Expressed in all |
CACNA1G | Calcium channel, voltage-dependent, T type, alpha 1G subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CATSPER4 | Cation channel, sperm associated 4 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCRL2 | Chemokine (C-C motif) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CD47 | CD47 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CDIPT | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CERS1 | Ceramide synthase 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CH25H | Cholesterol 25-hydroxylase | Enzymes Predicted membrane proteins
| | | | | Mixed |
CLN6 | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CLPTM1 | Cleft lip and palate associated transmembrane protein 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CMTM1 | CKLF-like MARVEL transmembrane domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CNGA1 | Cyclic nucleotide gated channel alpha 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
CNGA2 | Cyclic nucleotide gated channel alpha 2 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
CNGA4 | Cyclic nucleotide gated channel alpha 4 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNGB3 | Cyclic nucleotide gated channel beta 3 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CNNM2 | Cyclin and CBS domain divalent metal cation transport mediator 2 | Disease related genes Predicted membrane proteins
| | | | | Mixed |
CRLS1 | Cardiolipin synthase 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
CYB561 | Cytochrome b561 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYB561A3 | Cytochrome b561 family, member A3 | Predicted membrane proteins
| | | | | Expressed in all |